eli lilly glp 1 agonist is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating Eli Lilly releases topline data
Description
If the patient experiences gastrointestinal adverse effects during dose escalation, uptitration can be delayed for an additional week [21]
Lancet 381, 117124
10.1002/med.20142 21 MohsinS.BaniyasM
Because of this, Novo does not believe the pill will replace injectables
Evidence that commonly strengthens a claim includes medical records showing diagnosis and treatment, proof of lost wages, prescription and pharmacy records demonstrating Trulicity use, and qualified expert testimony linking the drug to the injury
ABLM, is a neurologist who has specialized in the care of persons with multiple sclerosis since 1982
